Comparison of Two Different Treatment Methods
Primary Purpose
Subacromial Impingement Syndrome, Musculoskeletal Diseases, Musculoskeletal Injury
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Kinesiotaping
Mulligan Mobilization Technique
Sponsored by
About this trial
This is an interventional treatment trial for Subacromial Impingement Syndrome focused on measuring Subacromial Impingement Syndrome, Mulligan Mobilization Technique, Kinesiotaping, Physiotherapy
Eligibility Criteria
Inclusion Criteria:
- Impingement symptoms in clinical tests
- Pain >1 month
Exclusion Criteria:
- Any shoulder pathology.
- Have chronic systemic diseases or infections.
- History of any surgery shoulder complex.
- steroid injections and therapeutic approaches
Sites / Locations
- Muğla Sıtkı Koçman University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Experimental
Experimental
Arm Label
Control Group (CG)
Kinesiotaping Group (KG)
Mulligan Mobilization Technique Group (MG)
Arm Description
Control group
Experimental group
Experimental group (2)
Outcomes
Primary Outcome Measures
Change of pain severity
Via VAS.
Change of Range of Motion
Via goniometer.
Change of Functionality
Via SPADI.
Secondary Outcome Measures
Change of Sleep Quality
Via VAS.
Change of Satisfaction of Life
Via SWLS.
Change of Satisfaction of Treatment
Via VAs.
Full Information
NCT ID
NCT05071469
First Posted
September 28, 2021
Last Updated
December 19, 2022
Sponsor
Banu BAYAR
Collaborators
Muğla Sıtkı Koçman University
1. Study Identification
Unique Protocol Identification Number
NCT05071469
Brief Title
Comparison of Two Different Treatment Methods
Official Title
Comparison of Short-term Effects of Two Different Treatment Methods in Patients With Subacromial Impingement Syndrome: a Randomized Controlled Single-blind Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
September 28, 2021 (Actual)
Primary Completion Date
October 15, 2021 (Actual)
Study Completion Date
November 30, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Banu BAYAR
Collaborators
Muğla Sıtkı Koçman University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).
Detailed Description
Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Subacromial Impingement Syndrome, Musculoskeletal Diseases, Musculoskeletal Injury, Musculoskeletal Pain, Weakness, Muscle
Keywords
Subacromial Impingement Syndrome, Mulligan Mobilization Technique, Kinesiotaping, Physiotherapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial
Masking
Outcomes Assessor
Masking Description
Single
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control Group (CG)
Arm Type
No Intervention
Arm Description
Control group
Arm Title
Kinesiotaping Group (KG)
Arm Type
Experimental
Arm Description
Experimental group
Arm Title
Mulligan Mobilization Technique Group (MG)
Arm Type
Experimental
Arm Description
Experimental group (2)
Intervention Type
Other
Intervention Name(s)
Kinesiotaping
Intervention Description
KT was applied.
Intervention Type
Other
Intervention Name(s)
Mulligan Mobilization Technique
Intervention Description
MMT was applied
Primary Outcome Measure Information:
Title
Change of pain severity
Description
Via VAS.
Time Frame
Baseline- after 2 weeks (after treatment)
Title
Change of Range of Motion
Description
Via goniometer.
Time Frame
Baseline- after 2 weeks (after treatment)
Title
Change of Functionality
Description
Via SPADI.
Time Frame
Baseline- after 2 weeks (after treatment)
Secondary Outcome Measure Information:
Title
Change of Sleep Quality
Description
Via VAS.
Time Frame
Baseline- after 2 weeks (after treatment)
Title
Change of Satisfaction of Life
Description
Via SWLS.
Time Frame
Baseline- after 2 weeks (after treatment)
Title
Change of Satisfaction of Treatment
Description
Via VAs.
Time Frame
Baseline- after 2 weeks (after treatment)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Impingement symptoms in clinical tests
Pain >1 month
Exclusion Criteria:
Any shoulder pathology.
Have chronic systemic diseases or infections.
History of any surgery shoulder complex.
steroid injections and therapeutic approaches
Facility Information:
Facility Name
Muğla Sıtkı Koçman University
City
Muğla
ZIP/Postal Code
48000
Country
Turkey
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Comparison of Two Different Treatment Methods
We'll reach out to this number within 24 hrs